Albuminuria is the most widely evaluated marker of kidney damage. Many previous studies have demonstrated an association between the presence of albuminuria and increased cardiovascular events. However, there are limited…
Guidelines do not recommend an implantable cardioverter defibrillator (ICD) for prevention of sudden death in patients who develop ventricular arrhythmia (VA) within 48 hours of acute myocardial infarction (AMI) if…
Monitoring anticoagulation using the activated clotting time (ACT) in patients treated with heparin and undergoing percutaneous coronary intervention (PCI) is one of the most frequently used tests in invasive cardiology….
Elucidating the optimal exercise intervention to improve arterial stiffness is a crucial vein of inquiry in the attempt to minimize cardiovascular morbidity and mortality. Alkatan et al. are therefore to be…
We read the recently published article by Ferrera et al entitled “Usefulness of new-onset atrial fibrillation, as a strong predictor of heart failure and death in patients with native left-sided infective…
We read the recent study by Ferrera et al highlighting the role of atrial fibrillation (AF) in patients with infective endocarditis. We would like to offer our thoughts on the correlation…
The presentation of acute pulmonary thromboembolism (PE) can be highly variable resulting in diagnostic challenges and management difficulties. Current guidelines suggest that therapy must be adjusted based on the severity…
We read with great interest, Kim et al’s study regarding the association of hospital volume with in-hospital outcomes after transcatheter aortic valve implantation (TAVI) in the United States. We would like…
Atrial fibrillation (AF) is the most common clinically relevant arrhythmia and increases the risk of thromboembolism and stroke; however, these risks are not the same for women and men. This…
